Triplet chemotherapy with paclitaxel, gemcitabine, and cisplatin as second-line therapy for advanced urothelial carcinoma

Journals Menu

Follow SCIRP

ISSN Print: 2169-348X
ISSN Online: 2169-3498
www.scirp.org/journal/mc
E-mail: mc@scirp.org

Citations h5-index & Ranking*

"Triplet chemotherapy with paclitaxel, gemcitabine, and cisplatin as second-line therapy for advanced urothelial carcinoma"
written by Hideki Takeshita, Koji Chiba, Sachi Kitayama, Shingo Moriyama, Rika Omura, Akira Noro,
published by Modern Chemotherapy, Vol.2 No.1, 2013

has been cited by the following article(s):

[1]	Investigation of the effects of curcumin, vitamin E and their combination in cisplatin-induced testicular apoptosis using immunohistochemical technique
	Turk J Urol, 2018

[2]	Protective effects of Eugenia jambolana extract versus N‐acetyl cysteine against cisplatin‐induced damage in rat testis
	Andrologia, 2015

Follow SCIRP

Free SCIRP Newsletters

Add your e-mail address to receive free newsletters from SCIRP.

Top

[1]	Mobile care app development process: using the ADDIE model to manage symptoms after breast cancer surgery (step 1) Discover Oncology, 2023 DOI:10.1007/s12672-023-00676-5

[2]	Protective effects ofEugenia jambolanaextract versus N-acetyl cysteine against cisplatin-induced damage in rat testis Andrologia, 2015 DOI:10.1111/and.12247